Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription

Science Translational Medicine

Volumn 2, Issue 32, 2010, Pages

  Wu, Ming Heng ^a,b   Ma, Wen Lung ^b,c   Hsu, Cheng Lung ^b,d   Chen, Yuh Ling ^a,b   Ou, Jing Hsiung James ^e   Ryan, Charlotte Kathryn ^b   Hung, Yao Ching ^c   Yeh, Shuyuan ^b   Chang, Chawnshang ^b,c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ANDROGEN RECEPTOR; DIETHYLNITROSAMINE; HEPATITIS B VIRUS X PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE TARGETING; HEPATITIS B VIRUS; HORMONE RESPONSIVE ELEMENT; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROMOTER REGION; RNA TRANSCRIPTION; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; TUMOR VOLUME; VIRUS CARCINOGENESIS; VIRUS CORE; VIRUS LOAD;

ANIMALS; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, VIRAL; CURCUMIN; DIETHYLNITROSAMINE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; RECEPTORS, ANDROGEN; RNA, VIRAL; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR BURDEN; VIRAL LOAD;

EID: 77952990855     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3001143     Document Type: Article

References (40)

1. C. J. Chen, M. W. Yu, Y. F. Liaw, Epidemiological characteristics and risk factors of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 12, S294-S308 (1997).
2. C. J. Chen, H. I. Yang, U. H. Iloeje; REVEAL-HBV Study Group, Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology 49, S72-S84 (2009).
3. M. W. Yu, Y. C. Yang, S. Y. Yang, S. W. Cheng, Y. F. Liaw, S. M. Lin, C. J. Chen, Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: A nested case-control study among men. J. Natl. Cancer Inst. 93, 1644-1651 (2001).
4. M. W. Yu, S.W. Cheng, M. W. Lin, S. Y. Yang, Y. F. Liaw, H. C. Chang, T. J. Hsiao, S. M. Lin, S. D. Lee, P. J. Chen, C. J. Liu, C. J. Chen, Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. J. Natl. Cancer Inst. 92, 2023-2028 (2000).
5. C. M. Lee, S. N. Lu, C. S. Changchien, C. T. Yeh, T. T. Hsu, J. H. Tang, J. H. Wang, D. Y. Lin, C. L. Chen, W. J. Chen, Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection. Cancer 86, 1143-1150 (1999).
6. Y. Shiratori, S. Shiina, M. Imamura, N. Kato, F. Kanai, T. Okudaira, T. Teratani, G. Tohgo, N. Toda, M. Ohashi, K. Ogura, Y. Niwa, T. Kawabe, M. Omata, Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan. Hepatology 22, 1027-1033 (1995).
7. N. Wang, Y. Zheng, X. Yu, W. Lin, Y. Chen, Q. Jiang, Sex-modified effect of hepatitis B virus infection on mortality from primary liver cancer. Am. J. Epidemiol. 169, 990-995 (2009).
8. Y. Zheng, W. L. Chen, S. G. Louie, T. S. Yen, J. H. Ou, Hepatitis B virus promotes hepatocarcinogenesis in transgenic mice. Hepatology 45, 16-21 (2007).
9. R. K. Ross, J. M. Yuan, M. C. Yu, G. N. Wogan, G. S. Qian, J. T. Tu, J. D. Groopman, Y. T. Gao, B. E. Henderson, Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 339, 943-946 (1992).
10. L. Ming, S. S. Thorgeirsson, M. H. Gail, P. Lu, C. C. Harris, N. Wang, Y. Shao, Z. Wu, G. Liu, X. Wang, Z. Sun, Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology 36, 1214-1220 (2002).
11. L. Y. Wang, M. Hatch, C. J. Chen, B. Levin, S.L. You, S. N. Lu, M. H. Wu, W. P. Wu, L. W. Wang, Q. Wang, G. T. Huang, P. M. Yang, H. S. Lee, R. M. Santella, Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int. J. Cancer 67, 620-625 (1996).
12. K. A. McGlynn, E. A. Rosvold, E. D. Lustbader, Y. Hu, M. L. Clapper, T. Zhou, C. P. Wild, X.-L. Xia, A. Baffoe-Bonnie, D. Ofori-Adjei, G.-C. Chen, W. T. London, F.-M. Shen, K. H. Buetow, Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc. Natl. Acad. Sci. U.S.A. 92, 2384-2387 (1995).
13. G. N. Wogan, Impacts of chemicals on liver cancer risk. Semin. Cancer Biol. 10, 201-210 (2000).
14. T. M. Earl, I. B. Nicoud, J. M. Pierce, J. P.Wright, N. E.Majoras, J. E. Rubin, K. P. Pierre, D. L. Gorden, R. S. Chari, Silencing of TLR4 decreases liver tumor burden in a murine model of colorectal metastasis and hepatic steatosis. Ann. Surg. Oncol. 16, 1043-1050 (2009).
15. D. K. Wong, M. F. Yuen, E. Tse, H. Yuan, S. S. Sum, C. K. Hui, C. L. Lai, Detection of intrahepatic hepatitis B virus DNA and correlation with hepatic necroinflammation and fibrosis. J. Clin. Microbiol. 42, 3920-3924 (2004).
16. S. Yeh, H. K. Lin, H. Y. Kang, T. H. Thin, M. F. Lin, C. Chang, From Her2/Neu signal cascade to androgen receptor and its coactivators: A novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proc. Natl. Acad. Sci. U.S.A. 96, 5458-5463 (1999).
17. S. H. Wang, S. H. Yeh, W. H. Lin, H. Y. Wang, D. S. Chen, P. J. Chen, Identification of androgen response elements in the enhancer I of hepatitis B virus: A mechanism for sex disparity in chronic hepatitis B. Hepatology 50, 1392-1402 (2009).
18. M. Singh, V. Kumar, Transgenic mouse models of hepatitis B virus-associated hepatocellular carcinoma. Rev. Med. Virol. 13, 243-253 (2003).
19. R. Nijhara, S. S. Jana, S. K. Goswami, A. Rana, S. S. Majumdar, V. Kumar, D. P. Sarkar, Sustained activation of mitogen-activated protein kinases and activator protein 1 by the hepatitis B virus X protein in mouse hepatocytes in vivo. J. Virol. 75, 10348-10358 (2001).
20. J. E. Kerr, S. G. Beck, R. J. Handa, Androgens selectively modulate c-Fos messenger RNA induction in the rat hippocampus following novelty. Neuroscience 74, 757-766 (1996).
21. P. Laurent-Puig, J. Zucman-Rossi, Genetics of hepatocellular tumors. Oncogene 25, 3778-3786 (2006).
22. J. A. DeLoia, R. D. Burk, J. D. Gearhart, Developmental regulation of hepatitis B surface antigen expression in two lines of hepatitis B virus transgenic mice. J. Virol. 63, 4069-4073 (1989).
23. B. Jilma, H. G. Eichler, C. Köppl, B. Weber, J. P. Pidlich, P. Ferenci, C. Müller, Effects of testosterone suppression on serum levels of hepatitis B surface antigen and HBV-DNA in men. Liver 18, 162-165 (1998).
24. Z. Yang, Y. J. Chang, I. C. Yu, S. Yeh, C. C. Wu, H. Miyamoto, D. E. Merry, G. Sobue, L. M. Chen, S. S. Chang, C. Chang, ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor. Nat. Med. 13, 348-353 (2007).
25. Y. F. Liaw, C. M. Chu, Hepatitis B virus infection. Lancet 373, 582-592 (2009).
26. J. D. Chen, H. I. Yang, U. H. Iloeje, S. L. You, S. N. Lu, L. Y. Wang, J. Su, C. A. Sun, Y. F. Liaw, C. J. Chen; Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer in HBV (REVEAL-HBV) Study Group, Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. Gastroenterology 138, 1747-1754 (2010).
27. W. L. Ma, C. L. Hsu, M. H. Wu, C. T. Wu, C. C. Wu, J. J. Lai, Y. S. Jou, C. W. Chen, S. Yeh, C. Chang, Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology 135, 947-955 (2008).
28. Y. Niu, S. Altuwaijri, S. Yeh, K. P. Lai, S. Yu, K. H. Chuang, S. P. Huang, H. Lardy, C. Chang, Targeting the stromal androgen receptor in primary prostate tumors at earlier stages. Proc. Natl. Acad. Sci. U.S.A. 105, 12188-12193 (2008).
29. Y. Niu, S. Altuwaijri, K. P. Lai, C. T. Wu, W. A. Ricke, E. M. Messing, J. Yao, S. Yeh, C. Chang, Androgen receptor is a tumor suppressor and proliferator in prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 105, 12182-12187 (2008).
30. Y. Niu, T. M. Chang, S. Yeh, W. L. Ma, Y. Wang, C. Chang, Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails. Oncogene 10.1038/onc.2010.121 (2010).
31. M. Mercader, B. K. Bodner, M. T. Moser, P. S. Kwon, E. S. Park, R. G. Manecke, T. M. Ellis, E. M. Wojcik, D. Yang, R. C. Flanigan, W. B. Waters, W. M. Kast, E. D. Kwon, T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 98, 14565-14570 (2001).
32. M. Ammirante, J. L. Luo, S. Grivennikov, S. Nedospasov, M. Karin, B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature 464, 302-305 (2010).
33. C. Berasain, J. Castillo, M. J. Perugorria, M. U. Latasa, J. Prieto, M. A. Avila, Inflammation and liver cancer: New molecular links. Ann. N. Y. Acad. Sci. 1155, 206-221 (2009).
34. L. G. Guidotti, F. V. Chisari, Immunobiology and pathogenesis of viral hepatitis. Annu. Rev. Pathol. 1, 23-61 (2006).
35. P. Allavena, A. Sica, G. Solinas, C. Porta, A. Mantovani, The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages. Crit. Rev. Oncol. Hematol. 66, 1-9 (2008).
36. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire, Randomized trial of leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen. Hepatology 40, 1361-1369 (2004).
37. S. Yeh, M. Y. Tsai, Q. Xu, X. M. Mu, H. Lardy, K. E. Huang, H. Lin, S. D. Yeh, S. Altuwaijri, X. Zhou, L. Xing, B. F. Boyce, M. C. Hung, S. Zhang, L. Gan, C. Chang, Generation and characterization of androgen receptor knockout (ARKO) mice: An in vivo model for the study of androgen functions in selective tissues. Proc. Natl. Acad. Sci. U.S.A. 99, 13498-13503 (2002).
38. Z. Yang, Y. J. Chang, H. Miyamoto, S. Yeh, J. L. Yao, P. A. di Sant'Agnese, M. Y. Tsai, C. Chang, Suppression of androgen receptor transactivation and prostate cancer cell growth by heterogeneous nuclear ribonucleoprotein A1 via interaction with androgen receptor coregulator ARA54. Endocrinology 148, 1340-1349 (2007).
39. R. P. Huang, A. Peng, M. Z. Hossain, Y. Fan, A. Jagdale, A. L. Boynton, Tumor promotion by hydrogen peroxide in rat liver epithelial cells. Carcinogenesis 20, 485-492 (1999).
40. N. Sawada, G. H. Lee, Y. Mochizuki, T. Ishikawa, Active proliferation of mouse hepatocytes in primary culture under defined conditions as compared to rat hepatocytes. Jpn. J. Cancer Res. 79, 983-988 (1988).